Recruitment

Recruitment Status
Terminated
Estimated Enrollment
50

Summary

Conditions
GI Patients on Oxaliplatin Containing Regimen
Type
Interventional
Phase
Early Phase 1
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03427021
Collaborators
Not Provided
Investigators
Principal Investigator: Kim Reiss Binder, MD Abramson Cancer Center of the University of Pennsylvania